our innovative device provides
real-time intraoperative data,
allowing surgeons to make key
decisions for better outcomes
we're quietly starting a med-tech revolution in the heart of Yorkshire
our mission is to deliver accessible innovation designed to improve patient outcomes
Our name, Eventum, means “outcome” in Latin, as patient outcomes are at the heart of our culture, and why our mission is to “deliver accessible innovation designed to improve patient outcomes”. With this as our focus we believe we help healthcare providers to deliver on the triple aim of improving the patient experience, improving the health of populations, and reducing per capita costs of health care.
The solution? We believe that the key to improving success rates is a greater focus on the positioning of the kneecap, which plays a significant role in the overall function of the knee.
* Millennium Research – Large-joint Reconstructive Implants, Med tech 360 US, Europe & Aisa Reports combined 2018/2019
**Heath, E. L., Ackerman, I. N., Cashman, K., Lorimer, M., Graves, S. E., & Harris, I. A. (2021). Patient-reported outcomes after hip and knee arthroplasty : results from a large national registry. Bone & joint open, 2(6), 422–432.
***Sensi, L., Buzzi, R., Giron, F., De Luca, L., & Aglietti, P. (2011). Patellofemoral function after total knee arthroplasty: gender-related differences. The Journal of arthroplasty, 26(8), 1475–1480.
The solution? We believe that the key to improving success rates is a greater focus on the positioning of the kneecap, which plays a significant role in the overall function of the knee.
Established in September 2020, Eventum is an award-winning Med Tech SME from the picturesque region of Yorkshire, England. Our mission revolves around addressing Orthopaedic problems with innovative solutions. Our team at Eventum is comprised of pragmatic and solution-oriented individuals who are passionate about enhancing patient outcomes. So far, we have achieved significant milestones, securing substantial funding from Mercia, Orthopaedic Surgeons, and Angel Investors during both the Seed and Series A rounds.
Our commitment led us on a relentless journey towards obtaining ISO 13485 Certification and acquiring the UKCA mark for our first patented product, Quadsense, which has gained endorsements from eminent surgeons worldwide. In a remarkable span of just over 18 months, Quadsense evolved from a mere concept to its first clinical use. Presently, we are pushing hard towards its commercial launch in the UK while simultaneously pursuing FDA approval in the United States.
We are a med-tech start up from Yorkshire, England, tackling complex problems with innovative solutions.
We are people like you: practical, solution focussed and driven by a desire too improve patient outcomes.
We have secured £1.4 million in funding from Mercia, Surgeons and Angel Investors, while our product design has received input from eminent surgeons worldwide.
We are a small, friendly team with expertise in Orthopaedic Surgery, Product Development, Global Strategic Marketing, Medical Device Sales, Engineering, Data Analytics, Finance and Start ups.
John Naybour
Chief Executive Officer
Paul Atherton
Chief Operations Officer
Jonathan Gonzalez
Finance Lead
Mike Cripps
Non-Executive Director
Alan Ashby
Non-Executive Chair
Joey Moore
Document Controller
Annabel Watson
Project Management Officer
Jeremy Whiting
Director of Technical and QARA
Paul Naybour
Founding Technical Consultant
Susie Naybour
Founding Technical Consultant